Alagpulinsa Laboratory
Investigating hematologic and cardiometabolic disease mechanisms to develop novel biomarkers for precision medicine and for drug discovery
The AlagsLab comprises an interdisclinary group that draws knowledge from diverse fields in the biomedical sciences, including genetics, molecular cell biology, immunology, pharmacology, biomedical engineering, and statistical and computational biology to investigate the mechanisms that underlie hematologic and cardiometabolic diseases and to design and develop novel therapies.
We are driven by a passion and commitment to improving human health through research and training the next generation of scientists and a mission to identify and validate disease biomarkers for precision medicine and to translate our findings to a preclinical stage that would facilitate transition to the bedside.
Principal Investigator
David A. Alagpulinsa, PhD
Assistant Professor